Anti-TNF Agents in Behçet's Disease Treatment

Semih Tatlıcan

Issue: Volume 24 - Issue 1 - June 2009
1273 3101

A Takayasu's Arteritis Case with Unilateral Digital Clubbing

Mahmut ÇİVİLİBAL, Nilgün SELÇUK DURU, Gafur DOĞDU, Murat ELEVLİ, Semih AYTA

DOI: 10.5606/tjr.2011.025

Issue: Volume 26 - Issue 2 - June 2011
5617 3913

The Reported Adverse Effects Related to Biological Agents Used for the Treatment of Rheumatic Diseases in Turkey

Erkan KILIÇ, Gamze KILIÇ, Özgür AKGÜL, Gürkan AKGÖL, Salih ÖZGÖÇMEN

DOI: 10.5606/tjr.2013.3052

Issue: Volume 28 - Issue 3 - September 2013
11172 2682

A Rare Kind of Lymphoma in a Patient on Treatment With Two Different Biological Agents

Inesa ARSTIKYTE, Irena BUTRIMIENE, Agne PETRULIONIENE, Algirdas VENALIS

DOI: 10.5606/ArchRheumatol.2015.4383

Issue: Volume 30 - Issue 1 - March 2015
5443 2405

Clinical Usefulness of Magnetic Resonance Imaging in Four Children With Scleroderma

Kazushi AGATA, Hisashi KAWASHIMA, Atsushi KUMADA, Yasuyo KASHIWAGI, Hiroko HARA

DOI: 10.5606/ArchRheumatol.2018.6498

Issue: Volume 33 - Issue 2 - June 2018
1480 1630

Certolizumab Pegol Treatment in Three Patients With Takayasu Arteritis

Nuh ATAŞ, Özkan VARAN, Hakan BABAOĞLU, Hasan SATIŞ, Reyhan BİLİCİ SALMAN, Abdurrahman TUFAN

DOI: 10.5606/ArchRheumatol.2019.7177

Issue: Volume 34 - Issue 3 - September 2019
127 332